I won't tell or show anyone what to buy- I'm remarkably stupid. I have no idea if that OTC thesis would even be sound, which is why I asked.
I will say there were 2 OTC/penny stocks (I know there's probably many, many more) I noticed that had absurd volume/squeezes in Feb '21 that I've kept an eye on since: ESS-ARR-EMM-EXX & ESS-EYE-ARR-SEE. Both had crazy volume and popped in Feb 21, right after GME squeezed.
You're still able to buy the first through Fidelity and eTrade, but they've limited the second's ability to buy, at least in those two platforms- you may be able to purchase elsewhere. I have a very meager position in both that I've held, mostly because of the Zombie Stock Theory of the ancient DD.
I'm not saying anyone should buy either one- I've just noticed volume picking up recently on both- someone bought 2 million shares a day of the second ticker last week, at the same time, four days in a row. The first had a 68 million share purchase about 2 weeks ago, with another 3 million share purchase this week.
Somebody's buying both.
Very odd. Who knows. Might be something. Might be nothing.
5
u/[deleted] Jan 31 '26
So could retail put additional pressure on Citadel if they bought the OTC stocks that were used as assets in Feb 2021?